trending Market Intelligence /marketintelligence/en/news-insights/trending/vra70bk7hnle4yo4fk1t_a2 content esgSubNav
In This List

Tetra Bio-Pharma completes acquisition of PhytoPain Pharma

Blog

Funding Social and Affordable Housing: A Credit Perspective

Blog

Global Capital Markets & SPAC Activity – H1 2021

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals


Tetra Bio-Pharma completes acquisition of PhytoPain Pharma

Tetra Bio-Pharma Inc. said it completed the acquisition of the remaining 20% of PhytoPain Pharma Inc. for C$12.4 million.

The Canadian medical cannabis company paid C$248,000 in cash, C$2.2 million in promissory notes and issued 2,485,218 of its shares for the interest.